Goldman Sachs Resumes Team Health (TMH) at Neutral

Go back to Goldman Sachs Resumes Team Health (TMH) at Neutral

Jefferies Says TeamHealth Holdings (TMH) is Positioned for Earnings Upside; Reiterates Buy

November 30, 2015 9:50 AM EST

Jefferies reiterated a Buy rating and $80.00 price target on Team Health (NYSE: TMH), under beliefs that the stock has room for upside. Jefferies says that the company is positioned to beat expectations in '16 as it realizes above-guidance synergies from IPCM and recognizes... More